Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Nexalin Technology, Inc. Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery July 18, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Closing of $5.2 Million Public Offering July 01, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Pricing of $5.2 Million Public Offering June 27, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia June 20, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa) June 13, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th June 04, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device June 03, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts May 22, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23 May 09, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements April 25, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing April 09, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device April 04, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board April 02, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego March 28, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology March 14, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment” March 13, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia March 06, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device February 08, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System January 23, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Unveils Next-Generation HALO™ Clarity January 11, 2024 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression December 18, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David Lasseter October 25, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures October 16, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms August 07, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time August 03, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies July 26, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury July 10, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific Region June 01, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory January 24, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Nexalin Technology CEO Provides Letter to Shareholders January 05, 2023 From Nexalin Technology, Inc. Via GlobeNewswire Tickers NXL NXLIW Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.